Having established the sGC co-expression WGCNA score as a valuable tool for assessing kidney outcomes relevant to DKD, we finally asked how pharmacological sGC modulation in the ZSF1 rat model would influence WGCNA score. The gene discussed is SGCB; the disease is diabetic kidney disease.